Your fact-checks will appear here
The FDA has issued warning letters to companies making unsubstantiated claims about treating diabetes.
Sugar Clean, as marketed online, carries multiple credibility problems: independent watchdogs and scam-analysis sites flag deceptive marketing, fake endorsements, and opaque company details, while the...
No public warning letter naming "-claim">Glycopezil" or its operators appears in the reporting provided; FDA has issued warning letters broadly against companies selling products that claim to treat d...
Since 2015 the has continued to challenge dietary-supplement marketers that advertise , securing a mix of court wins, consent orders and proposed settlements aimed at products advertised to treat chro...
Federal agencies have robust authority and an active enforcement posture against deceptive health‑product advertising and misleading endorsements — and they have used warning letters, guidance, and en...
Since 2020 the Federal Trade Commission has pursued a mix of administrative and enforcement measures against sellers of diabetes supplements that make unproven treatment claims: the agency issued ceas...